JPRN-UMIN000004691已完成2 期
A phase 2 study of combination chemotherapy for hepatocellular carcinoma using Miripla (SM11355) and IA-call (DDP-H) - Combination chemotherapy of SM11355 and DDP-H for HCC
iigata Hepatocellular Carcinoma Therapy Study Group0 个研究点目标入组 200 人开始时间: 2011年9月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Pleural effusion and/or ascites refractory to treatments. 2) Comorbidity: >Active infectious diseases except for hepatitis. >Active bleeding from GI tract. >Active concomitant cancer with invasive nature. >Severe mental disorder or hepatic encephalopathy. 3) A history of severe allergic reaction against iodine contrast medium and/or platinum agents. 4) A pregnant or lactating female or female of childbearing age unless using effective contraception. 5) Ongoing interferon therapy. 6) Difficulties of oral intake. 7) Other serious conditions judged to be inadequate by a responsible doctor.
研究者
相似试验
已完成
1 期
A phase 1 study of combination chemotherapy for hepatocellular carcinoma using Miripla® (SM11355) and IA-call® (DDP-H)Hepatocellular carcinomaJPRN-UMIN000003541iigata Hepatocellular Carcinoma Therapy Study Group18
已完成
2 期
Phase II study of combination chemotherapy and high-dose chemotherapy in treating young children with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumorsmedulloblastoma or supratentorial primitive neuroectodermal tumorsJPRN-UMIN000000546Japanese Pediatric Brain Tumor Consortium40
招募中
2 期
Phase II study of combination chemotherapy using paclitaxel, carboplatin, and bevacizumab in patients with advanced or recurrent cervical cancer.cervical cancerJPRN-UMIN000024137Hyogo Cancer Center30
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced lung squamous cell carcinomaung cancerJPRN-UMIN000006983Hamamatsu University School of Medicine50
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancernon-small-cell lung cancerJPRN-UMIN000010189ational Hospital Organization Osaka20